On December 05, 2022, Vimedimex Medi – Pharma Joint Stock Company announces the Resolution of the extraordinary general shareholders’ meeting (EGM)to approve the following contents:
- The AGM approved to the amendment, supplement of the Articles of Association.
- The AGM approved to the amendment, supplement of the Internal corporate governance regulation.
- The AGM approved to the amendment, supplement of the BOD activities regulation.
- The AGM approved to the amendment, supplement of the BOS activities regulation.
- The AGM approved operating model business model on CEVPharma international E-Commerce Exchange.
- The AGM approved to the selection Cermed GmbH strategic investor.
- The AGM approved the selection the auditor for the financial statements in 2022 - 2025.
- The AGM approved the stock issuance to raise its charter capital:
- Stock volume before the issuance: 15,440,268 dongs
- Expected issuance volume: 3,088,054
- Stock volume after the issuance: 18,528,322 dongs
- Price of issuance: VND29,000/share
- Total value of issuance: VND 89,553,566,000
- Expected charter capital after the issuance: VND185,283,216,000
- Implement time: in 2023
- Purpose of using capital: to supplement working capital for CEVPharma international E-Commerce Exchange.
9. Approving the resignation & election of members to the Board of Directors and another member to the Supervisory Board in the term 2022-2027:
- The resignation of members to the Board of Directors:
Mr. Tran Dinh Huynh
Mrs. To Thuy Anh
- The election of members to the Board of Directors:
Mr. Trinh Thanh Giang
Mr. Christian Achlennstedt.
- The AGM did not approve the resignation letter from Mrs. Pham Thi Thu Thao as a member of the Supervisory Board.